Lilly files more lawsuits to curb sales of counterfeit Mounjaro
Publishing timestamp: 2024-06-20 11:50:52
Summary
Eli Lilly is suing entities for selling products falsely claiming to contain tirzepatide, the active ingredient in its diabetes drug. The company is concerned about the safety risks of counterfeit versions of its drug and demand for GLP-1 drugs is outpacing supply. FDA has warned about the safety risks of using compounded versions of weight-loss drugs.
Sentiment: NEGATIVE
Keywords: novo nordisk a/s, business, lawsuits, health care industry, pharmaceuticals, lilly drn, biotech and pharmaceuticals, business news,
Source: https://www.cnbc.com/2024/06/20/lilly-files-more-lawsuits-to-curb-sales-of-counterfeit-mounjaro.html